Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.

Grünig E, Eichstaedt C, Barberà JA, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M, D'Andrea A, Delcroix M, de Man F, Gaine S, Ghio S, Gibbs S, Gumbiene L, Howard LS, Johnson M, Jurevičienė E, Kiely DG, Kovacs G, MacKenzie A, Marra AM, McCaffrey N, McCaughey P, Naeije R, Olschewski H, Pepke-Zaba J, Reis A, Santos M, Saxer S, Tulloh RM, Ulrich S, Vonk Noordegraaf A, Peacock AJ.

Eur Respir J. 2019 Feb 28;53(2). pii: 1800332. doi: 10.1183/13993003.00332-2018. Print 2019 Feb.

PMID:
30578391
2.

Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week.

Dimopoulos K, Condliffe R, Tulloh RMR, Clift P, Alonso-Gonzalez R, Bedair R, Chung NAY, Coghlan G, Fitzsimmons S, Frigiola A, Howard LS, Jenkins P, Kenny D, Li W, MacDonald ST, McCabe C, Oliver JJ, Spence MS, Szantho GV, von Klemperer K, Wilson DG, Wort SJ; CHAMPION Steering Committee.

J Am Coll Cardiol. 2018 Dec 4;72(22):2778-2788. doi: 10.1016/j.jacc.2018.08.2201. Review.

3.

Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015.

Tulloh RMR, Mayon-White R, Harnden A, Ramanan AV, Tizard EJ, Shingadia D, Michie CA, Lynn RM, Levin M, Franklin OD, Craggs P, Davidson S, Stirzaker R, Danson M, Brogan PA.

Arch Dis Child. 2018 Aug 13. pii: archdischild-2018-315087. doi: 10.1136/archdischild-2018-315087. [Epub ahead of print]

PMID:
30104394
4.

Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease.

Condliffe R, Clift P, Dimopoulos K, Tulloh RMR.

Pulm Circ. 2018 Jul-Sep;8(3):2045894018792501. doi: 10.1177/2045894018792501. Epub 2018 Jul 23.

5.

Respiratory virus prophylaxis in congenital heart disease.

Joshi M, Tulloh RM.

Future Cardiol. 2018 Sep;14(5):417-425. doi: 10.2217/fca-2017-0096. Epub 2018 Jun 7.

PMID:
29877720
6.

A pilot randomised controlled trial investigating a mindfulness-based stress reduction (MBSR) intervention in individuals with pulmonary arterial hypertension (PAH): the PATHWAYS study.

Tulloh RMR, Garratt V, Tagney J, Turner-Cobb J, Marques E, Greenwood R, Howard L, Gin-Sing W, Barton A, Ewings P, Craggs P, Hollingworth W.

Pilot Feasibility Stud. 2018 May 21;4:78. doi: 10.1186/s40814-018-0270-z. eCollection 2018.

7.

Pulmonary hypertension in congenital heart disease.

Pascall E, Tulloh RM.

Future Cardiol. 2018 Jul;14(4):343-353. doi: 10.2217/fca-2017-0065. Epub 2018 May 24.

8.

Primary repair versus surgical and transcatheter palliation in infants with tetralogy of Fallot.

Dorobantu DM, Mahani AS, Sharabiani MTA, Pandey R, Angelini GD, Parry AJ, Tulloh RMR, Martin RP, Stoica SC.

Heart. 2018 Nov;104(22):1864-1870. doi: 10.1136/heartjnl-2018-312958. Epub 2018 May 2.

PMID:
29720396
9.

Giant coronary artery aneurysms in a 12-week-old infant with incomplete Kawasaki disease.

Guile L, Parke S, Kelly A, Tulloh R.

BMJ Case Rep. 2018 Mar 28;2018. pii: bcr-2018-224479. doi: 10.1136/bcr-2018-224479.

10.

The cardiac proteome in patients with congenital ventricular septal defect: A comparative study between right atria and right ventricles.

Bond AR, Iacobazzi D, Abdul-Ghani S, Ghorbel MT, Heesom KJ, George SJ, Caputo M, Suleiman MS, Tulloh RM.

J Proteomics. 2019 Jan 16;191:107-113. doi: 10.1016/j.jprot.2018.03.022. Epub 2018 Mar 20.

11.

Lung Function, Inflammation, and Endothelin-1 in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.

Low A, George S, Howard L, Bell N, Millar A, Tulloh RMR.

J Am Heart Assoc. 2018 Feb 14;7(4). pii: e007249. doi: 10.1161/JAHA.117.007249.

12.

Changes in contractile protein expression are linked to ventricular stiffness in infants with pulmonary hypertension or right ventricular hypertrophy due to congenital heart disease.

Bond AR, Iacobazzi D, Abdul-Ghani S, Ghorbel M, Heesom K, Wilson M, Gillett C, George SJ, Caputo M, Suleiman S, Tulloh RMR.

Open Heart. 2018 Jan 3;5(1):e000716. doi: 10.1136/openhrt-2017-000716. eCollection 2018.

13.

Management of Adults With Congenital Heart Disease and Pulmonary Arterial Hypertension in the UK: Survey of Current Practice, Unmet Needs and Expert Commentary.

Tulloh R, Dimopoulos K, Condliffe R, Clift P; CHAMPION Steering Committee.

Heart Lung Circ. 2018 Aug;27(8):1018-1027. doi: 10.1016/j.hlc.2017.10.018. Epub 2017 Nov 13.

14.

The Perception of a Three-Dimensional-Printed Heart Model from the Perspective of Different Stakeholders: A Complex Case of Truncus Arteriosus.

Biglino G, Moharem-Elgamal S, Lee M, Tulloh R, Caputo M.

Front Pediatr. 2017 Sep 28;5:209. doi: 10.3389/fped.2017.00209. eCollection 2017.

15.

Kawasaki disease and coronary artery aneurysms: from childhood to adulthood.

Joshi M, Tulloh R.

Future Cardiol. 2017 Aug 22. doi: 10.2217/fca-2017-0039. [Epub ahead of print]

PMID:
28828893
16.

Retrospective study of the impact of unrecognised Kawasaki disease, coronary aneurysm and ectasia.

Waterhouse BR, Tulloh RMR, Kim Y, Creasy W, Adlam D, Johnson TW.

Int J Cardiol. 2017 Dec 1;248:308-313. doi: 10.1016/j.ijcard.2017.08.018. Epub 2017 Aug 10.

PMID:
28818354
17.

Sildenafil in Infants and Children.

Simonca L, Tulloh R.

Children (Basel). 2017 Jul 24;4(7). pii: E60. doi: 10.3390/children4070060. Review.

18.

CHD and respiratory syncytial virus: global expert exchange recommendations.

Tulloh RMR, Medrano-Lopez C, Checchia PA, Stapper C, Sumitomo N, Gorenflo M, Jung Bae E, Juanico A, Gil-Jaurena JM, Wu MH, Farha T, Dodge-Khatami A, Tsang R, Notario G, Wegzyn C.

Cardiol Young. 2017 Oct;27(8):1504-1521. doi: 10.1017/S1047951117000609. Epub 2017 Jun 16.

PMID:
28619123
19.

Early Experience of Macitentan for Pulmonary Arterial Hypertension in Adult Congenital Heart Disease.

Herbert S, Gin-Sing W, Howard L, Tulloh RMR.

Heart Lung Circ. 2017 Oct;26(10):1113-1116. doi: 10.1016/j.hlc.2016.12.011. Epub 2017 Feb 6.

PMID:
28237536
20.

Corticosteroids for the treatment of Kawasaki disease in children.

Wardle AJ, Connolly GM, Seager MJ, Tulloh RM.

Cochrane Database Syst Rev. 2017 Jan 27;1:CD011188. doi: 10.1002/14651858.CD011188.pub2. Review.

PMID:
28129459
21.

The incidence of Kawasaki disease after vaccination within the UK pre-school National Immunisation Programme: an observational THIN database study.

Hall GC, Tulloh RM, Tulloh LE.

Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1331-1336. doi: 10.1002/pds.4108. Epub 2016 Sep 21.

PMID:
27651105
22.

Sildenafil, pulmonary hypertension and bronchopulmonary dysplasia.

Herbert S, Tulloh R.

Early Hum Dev. 2016 Nov;102:21-24. doi: 10.1016/j.earlhumdev.2016.09.009. Epub 2016 Sep 21.

PMID:
27665322
23.

Guanylate cyclase stimulators for pulmonary hypertension.

Wardle AJ, Seager MJ, Wardle R, Tulloh RM, Gibbs JS.

Cochrane Database Syst Rev. 2016 Aug 2;(8):CD011205. doi: 10.1002/14651858.CD011205.pub2. Review.

PMID:
27482837
24.

Kawasaki disease incidence in children and adolescents: an observational study in primary care.

Hall GC, Tulloh LE, Tulloh RM.

Br J Gen Pract. 2016 Apr;66(645):e271-6. doi: 10.3399/bjgp16X684325. Epub 2016 Feb 23.

25.

Cellular and molecular basis of RV hypertrophy in congenital heart disease.

Iacobazzi D, Suleiman MS, Ghorbel M, George SJ, Caputo M, Tulloh RM.

Heart. 2016 Jan;102(1):12-7. doi: 10.1136/heartjnl-2015-308348. Epub 2015 Oct 29. Review.

26.

Cardiovascular status after Kawasaki disease in the UK.

Shah V, Christov G, Mukasa T, Brogan KS, Wade A, Eleftheriou D, Levin M, Tulloh RM, Almeida B, Dillon MJ, Marek J, Klein N, Brogan PA.

Heart. 2015 Oct;101(20):1646-55. doi: 10.1136/heartjnl-2015-307734. Epub 2015 Aug 27.

27.

Anomalous Left Coronary From the Pulmonary Artery Presenting as Ventricular Fibrillation After Persistent Ductus Arteriosus Ligation.

Fudulu DP, Tulloh RM, Wolf AR, Parry AJ, Stoica SC.

Ann Thorac Surg. 2015 Jul;100(1):e9-e10. doi: 10.1016/j.athoracsur.2015.04.015.

PMID:
26140805
28.

Lung function in pulmonary hypertension.

Low AT, Medford AR, Millar AB, Tulloh RM.

Respir Med. 2015 Oct;109(10):1244-9. doi: 10.1016/j.rmed.2015.05.022. Epub 2015 May 27. Review.

29.

Sildenafil in bronchopulmonary dysplasia: safe to use?

Wardle AJ, Connolly GM, Stonier T, Tulloh R.

Arch Dis Child Fetal Neonatal Ed. 2015 Jul;100(4):F369. doi: 10.1136/archdischild-2015-308164. Epub 2015 Feb 25. No abstract available.

PMID:
25716676
30.

Pulmonary arterial hypertension exacerbated by ruxolitinib.

Low AT, Howard L, Harrison C, Tulloh RM.

Haematologica. 2015 Jun;100(6):e244-5. doi: 10.3324/haematol.2014.120816. Epub 2015 Feb 14. No abstract available.

31.

Fifteen-minute consultation: rheumatic fever.

Markham R, Tulloh R.

Arch Dis Child Educ Pract Ed. 2015 Aug;100(4):176-9. doi: 10.1136/archdischild-2014-306545. Epub 2015 Feb 4. Review.

PMID:
25653243
32.

Authors' response to 'aspirin dose for treatment of Kawasaki disease'.

Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein N, Brogan P.

Arch Dis Child. 2015 Mar;100(3):300-1. doi: 10.1136/archdischild-2014-307798. Epub 2014 Nov 25. No abstract available.

PMID:
25425602
33.

Kawasaki disease.

Harnden A, Tulloh R, Burgner D.

BMJ. 2014 Sep 17;349:g5336. doi: 10.1136/bmj.g5336. Review. No abstract available.

PMID:
25230954
34.

Does the persistence of pulsatile antegrade pulmonary blood flow following bidirectional Glenn procedure affect long term outcome?

Chen Q, Tulloh R, Caputo M, Stoica S, Kia M, Parry AJ.

Eur J Cardiothorac Surg. 2015 Jan;47(1):154-8; discussion 158. doi: 10.1093/ejcts/ezu170. Epub 2014 Apr 30.

PMID:
24787474
35.

Prevention and prophylaxis of respiratory syncytial virus in pediatric cardiology: a UK perspective.

Tulloh RM, Bury S.

Future Cardiol. 2014 Mar;10(2):235-42. doi: 10.2217/fca.14.4. Review.

PMID:
24762251
36.

Comparison of the effect of inhaled anaesthetic with intravenous anaesthetic on pulmonary vascular resistance measurement during cardiac catheterisation.

Giesen LA, White M, Tulloh RM.

Cardiol Young. 2015 Feb;25(2):368-72. doi: 10.1017/S1047951114000195. Epub 2014 Feb 19.

PMID:
24548796
37.

Adaptations of aortic and pulmonary artery flow parameters measured by phase-contrast magnetic resonance angiography during supine aerobic exercise.

Pieles GE, Szantho G, Rodrigues JC, Lawton CB, Stuart AG, Bucciarelli-Ducci C, Turner MS, Williams CA, Tulloh RM, Hamilton MC.

Eur J Appl Physiol. 2014 May;114(5):1013-23. doi: 10.1007/s00421-014-2833-x. Epub 2014 Feb 7.

PMID:
24504653
38.

Management of Kawasaki disease.

Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA.

Arch Dis Child. 2014 Jan;99(1):74-83. doi: 10.1136/archdischild-2012-302841. Epub 2013 Oct 25. Review.

39.

Patent ductus arteriosus: an analysis of management.

Wardle AJ, Osman A, Tulloh R, Luyt K.

Cardiol Young. 2014 Oct;24(5):941-3. doi: 10.1017/S1047951113001583. Epub 2013 Oct 24.

PMID:
24153161
40.

High haematocrit in cyanotic congenital heart disease affects how fibrinogen activity is determined by rotational thromboelastometry.

Westbury SK, Lee K, Reilly-Stitt C, Tulloh R, Mumford AD.

Thromb Res. 2013 Aug;132(2):e145-51. doi: 10.1016/j.thromres.2013.07.006. Epub 2013 Jul 30.

PMID:
23906940
41.

Paediatric pulmonary hypertension and sildenafil: current practice and controversies.

Wardle AJ, Tulloh RM.

Arch Dis Child Educ Pract Ed. 2013 Aug;98(4):141-7. doi: 10.1136/archdischild-2013-303981. Epub 2013 Jun 15.

PMID:
23771819
42.

The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia.

Wardle AJ, Wardle R, Luyt K, Tulloh R.

Arch Dis Child. 2013 Aug;98(8):613-7. doi: 10.1136/archdischild-2012-303333. Epub 2013 Apr 26. Review.

PMID:
23625986
43.

Evolving management of pediatric pulmonary arterial hypertension: impact of phosphodiesterase inhibitors.

Wardle AJ, Tulloh RM.

Pediatr Cardiol. 2013 Feb;34(2):213-9. doi: 10.1007/s00246-012-0598-8. Epub 2012 Dec 19. Review.

PMID:
23250648
44.

Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension.

Skinner GJ, Tulloh RM, Tometzki AJ, Schulze-Neick I, Morgan GJ.

Cardiol Young. 2013 Oct;23(5):692-6. doi: 10.1017/S1047951112001771. Epub 2012 Oct 23.

PMID:
23089055
45.

[Aortic isthmus stenosis in newborn infants].

Punukollu M, Harnden A, Tulloh R.

Praxis (Bern 1994). 2012 Mar 14;101(6):407-11. doi: 10.1024/1661-8157/a000891. Review. German. No abstract available.

PMID:
22419139
46.

Management of pulmonary hypertension and Down syndrome.

King P, Tulloh R.

Int J Clin Pract Suppl. 2011 Dec;(174):8-13. doi: 10.1111/j.1742-1241.2011.02823.x. Review.

PMID:
22171818
47.

Coarctation of the aorta in the newborn.

Punukollu M, Harnden A, Tulloh R.

BMJ. 2011 Nov 16;343:d6838. doi: 10.1136/bmj.d6838. No abstract available.

PMID:
22088486
48.

The sinister course of an intramural right coronary artery.

Yim DL, Hamilton MC, Tulloh RM.

Cardiol Young. 2012 Apr;22(2):206-8. doi: 10.1017/S104795111100103X. Epub 2011 Jul 19.

PMID:
21771384
49.

A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease.

Feltes TF, Sondheimer HM, Tulloh RM, Harris BS, Jensen KM, Losonsky GA, Griffin MP; Motavizumab Cardiac Study Group.

Pediatr Res. 2011 Aug;70(2):186-91. doi: 10.1203/PDR.0b013e318220a553.

PMID:
21522037
50.

Management of pulmonary hypertension in Down syndrome.

Hawkins A, Langton-Hewer S, Henderson J, Tulloh RM.

Eur J Pediatr. 2011 Jul;170(7):915-21. doi: 10.1007/s00431-010-1378-1. Epub 2011 Jan 4.

PMID:
21203772

Supplemental Content

Loading ...
Support Center